Safety and immunogenicity of two octavalent pneumococcal conjugate vaccines in American Indian infants (Q47993902)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in March 2004

Language	Label	Description	Also known as
English	Safety and immunogenicity of two octavalent pneumococcal conjugate vaccines in American Indian infants	scientific article published in March 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

Safety and immunogenicity of two octavalent pneumococcal conjugate vaccines in American Indian infants (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

Robert Weatherholtz

3

object named as

Robert Weatherholtz

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

Mathuram Santosham

5

object named as

Mathuram Santosham

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

author name string

Angelia Eick

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

Janné Croll

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

Larry Croll

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

22

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

9-10

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

1260-1264

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

High incidence rates of invasive pneumococcal disease in the White Mountain Apache population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.026

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.09.026

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/15003655

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47993902&oldid=2180933620"